In Vitro Chemotherapeutic Combinations Against Isoniazid-Resistant Mycobacterium tuberculosis and Mycobacterium fortuitum

It is an acceptable medical practice to use second-line antimycobacterial drugs in combination with isoniazid in treatment of isoniazid-resistant tuberculosis. Recent investigations have demonstrated the importance of determining chemotherapeutic interaction in instances of multiple antibiotic use....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Appl Microbiol
Egile Nagusiak: Goldstein, Elliot, Eagle, M. Carroll, LaCasse, M. L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 1971
Gaiak:
Clinical Microbiology, Virology, and Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC376309/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4330314/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/am.22.3.329-333.1971
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak